S. 2620
119th Congress
Senate
REMEDY Act
Official title: A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to approval of abbreviated new drug applications.
Everywhere this bill has been
2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jul 31, 2025
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text: CR S5000)
Jul 31, 2025
Introduced in Senate
Ask about this bill
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
What's happening now
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text: CR S5000)
Bill text
1 version
- Introduced in Senate Formatted Text PDF Formatted XML
Committees of jurisdiction
1
Lobbying activity
21
- AMERICA'S HEALTH INSURANCE PLANS, INC. (AHIP)
- PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
- GSK (FKA GLAXOSMITHKLINE INC.)
- KAISER FOUNDATION HEALTH PLAN INC.
- AMERICA'S HEALTH INSURANCE PLANS, INC. (AHIP)
- KAISER FOUNDATION HEALTH PLAN INC.
Bodies those filers lobbied
- SENATE
- Centers For Medicare and Medicaid Services (CMS)
- Health & Human Services, Dept of (HHS)
- HOUSE OF REPRESENTATIVES
- Patent & Trademark Office (PTO)
- Executive Office of the President (EOP)
- Labor, Dept of (DOL)
- White House Office
Cosponsors
1
Cite this page
U.S. Congress. (2026). S. 2620: REMEDY Act. 119th Congress. Open America. https://openamerica.io/bill/119-S-2620/
"S. 2620: REMEDY Act." 119th Congress, 2026, Open America, https://openamerica.io/bill/119-S-2620/.
S. 2620, 119th Cong. (2026), https://openamerica.io/bill/119-S-2620/.
[S. 2620: REMEDY Act](https://openamerica.io/bill/119-S-2620/)